Risk Factors for Retinopathy in Type 1 Diabetes: The DCCT/EDIC Study.


Biostatistics Center, The George Washington University, Washington, DC [Email]


The Diabetes Control and Complications Trial (DCCT) demonstrated that intensive therapy reduced the development and progression of retinopathy in type 1 diabetes (T1D) compared with conventional therapy. The Epidemiology of Diabetes Interventions and Complications (EDIC) study observational follow-up showed persistent benefits. In addition to glycemia, we now examine other potential retinopathy risk factors (modifiable and nonmodifiable) over more than 30 years of follow-up in DCCT/EDIC.

OUR Recent Articles